In-vitro Diagnostics (IVD) Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, Germany, China, Japan - Size and Forecast 2024-2028

Published: Nov 2023 Pages: 179 SKU: IRTNTR71317

In vitro Diagnostics (IVD) Market Forecast 2024-2028

The In-vitro Diagnostics (IVD) Market size is estimated to grow by USD 22.17 billion at a CAGR of 4.21% between 2023 and 2028. One of the key factors driving the market growth and trends is the increasing geriatric population and chronic and infectious diseases. The growing population and prevalence of infectious and chronic diseases like cancer and diabetes in all cohorts require regular diagnostic testing. For instance, as per the WHO, as of 2020, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths.

A key factor shaping the market growth is the global adoption of advanced treatment solutions. There is an increasing use and adoption to manage and test for cancer, CVD, and infectious kidney diseases with immunoassay and molecular diagnostic devices. In addition, the availability of advanced treatment care also enables increased adoption rates among healthcare providers.

What will be the Size of the Market During the Forecast Period?

To learn more about this report, Download Report Sample

Market Segmentation by Product Type Analysis 

The reagents and kits segment is estimated to witness significant growth during the forecast period. The reagents are chemical substances that react with specific biological markers and enable the detection or measurement of target analytes in patient samples. In addition, the diagnostic kits, on the other hand, are comprehensive packages that typically include reagents, calibrators, controls, and sometimes instruments, offering a complete solution for specific diagnostic tests.

Get a glance at the market contribution of various segments Download PDF Sample

The reagents and kits segment was the largest segment and was valued at USD 58.86 billion in 2018. Moreover, in the IVD landscape, reagents and kits cater to a wide array of applications, from routine clinical chemistry to specialized molecular diagnostics. For example, in clinical chemistry, reagents are employed to measure substances such as glucose, cholesterol, and enzymes in blood samples, aiding in the assessment of various medical conditions, including diabetes and cardiovascular diseases. In addition, immunoassay kits utilize antibodies and antigens to detect proteins or hormones, supporting the diagnosis of infectious diseases, hormonal disorders, and autoimmune conditions. Hence, such factors are fuelling the growth of this segment which in turn will drive the  (IVD) market growth during the forecast period.

Technology Analysis 

The immunochemistry segment is a branch of chemistry, which comprises the study of molecular mechanisms and functions of the immune system through interactions between antigens and corresponding antibodies. In addition, this technique is primarily focused on the identification and documentation of high-resolution cellular components within cells and tissue constituents, such as proteins and lipopolysaccharides in clinical diagnostics and medical research laboratories. Furthermore, it is used to diagnose diseases, for biological research, and for drug development applications. Hence, such factors are fuelling the growth of this segment which in turn drives the IVD market growth during the forecast period.

Regional Analysis

For more insights about the market share of various regions Download PDF Sample now!

North America is estimated to contribute 39% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. Some of the main factors that are contributing to the market growth include increased insurance coverage, rise in R&D  expenditure, growth of geriatric population with chronic diseases, high healthcare spending, and increase in promotions about the use of POC tests for the early detection of diseases.

In addition, according to the Centers for Disease Control and Prevention (CDC), six in 10 adults in the US have chronic diseases as the leading cause of death and disability. Immunodiagnostics dominates the instruments market in the US due to the demand for reagents and instruments for effective diagnosis. Moreover, the Indiana, Ohio, and Illinois states of the Midwest region in the US are expected to grow at a faster pace due to their increasing number of accredited laboratories and reimbursements by Medicare. Hence, such factors are driving the market growth in North America during the forecast period.

Buy Full Report Now

Market Dynamics and Customer Landscape

The in-vitro diagnostics market is witnessing robust growth, driven by factors such as the increasing geriatric population and the prevalence of chronic and infectious diseases. This surge in demand is further fueled by the global adoption of advanced treatment solutions, leading to greater emphasis on diagnostic accuracy and efficiency. However, the industry faces challenges, notably the lack of skilled professionals capable of operating semi-automated instruments and conducting rapid tests effectively.

Additionally, healthcare infrastructure and technology advancements play pivotal roles in shaping the market landscape. Amidst these dynamics, product approval for innovations like Real-time reverse transcription (qRT) PCR-based diagnostic kits and Early cancer detection (ECD) market solutions are crucial for meeting evolving healthcare needs. Overcoming challenges related to recession and ensuring alignment with breakthrough device designations (BDDs) are essential for sustained growth in this vital segment of the healthcare industry.. 

Key Market Drivers

One of the key factors driving the market growth is the increasing geriatric population and chronic, and infectious diseases. The growing population and prevalence of infectious and chronic diseases like cancer and diabetes in all cohorts require regular diagnostic testing. For instance, as per the WHO, as of 2020, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. 

Moreover, the trend of chronic diseases is likely to continue with unhealthy dietary habits, a sedentary lifestyle, high tobacco and alcohol consumption, and obesity being some of the prime factors contributing to the prevalence of these diseases. Hence, such factors are positively impacting the market. Therefore, it is expected to drive the market growth during the forecast period.

Significant Market Trends

A key factor shaping the market growth is the global adoption of advanced treatment solutions. There is an increasing use and adoption to manage and test for cancer, CVD, and infectious kidney diseases with immunoassay and molecular diagnostic devices. In addition, the availability of advanced treatment care also enables increased adoption rates among healthcare providers. 

For example, Xprecia Stride Coagulation Analyzer by Siemens is a handheld device that performs ProTime INR (PT/INR) tests with high accuracy. In addition, even though routine diagnostic testing currently has a higher volume of activity, the growth of specialty testing in esoteric, pathology, and genetic testing areas is said to outpace in the forecasted year. Hence, such factors are positively impacting the market. Therefore, it is expected to drive the market trends and analysis during the forecast period.

Major Market Challenges

The lack of skilled professionals is one of the key challenges hindering the market growth. A majority of critical diagnostic tests such as clinical chemistry, immunoassay, and molecular diagnosis need trained professionals with increased dexterity skills to handle tools and accurately perform the technique. However, the market has a shortage of skilled personnel to handle these devices.

Moreover, several factors that are responsible for this shortfall are the immigration of well-established trained specialists from developing countries to developed countries, lack of standardization and prescribed curriculum knowledge on techniques, and lack of proper training in handling devices. Furthermore, the need for expensive and multiyear theoretical studies to become qualified professionals or technicians also contributes to the shortage of skilled professionals. Hence, such factors are negatively impacting the market. Therefore, it is expected to hinder the market growth during the forecast period.

Buy Now Full Report

Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Abbott Laboratories: The company offers in vitro diagnostics such as the Alinity h series and CELL DYN Ruby. 

  • Agilent Technologies Inc.
  • ARKRAY Inc.
  • Becton Dickinson and Co.
  • BGI Genomics Co. Ltd.
  • Bio Rad Laboratories Inc.
  • bioMerieux SA
  • Charles River Laboratories International Inc.
  • Danaher Corp.
  • DiaSorin SpA
  • F. Hoffmann La Roche Ltd.
  • Grifols SA
  • Illumina Inc.
  • Merck KGaA
  • QIAGEN NV
  • Quest Diagnostics Inc.
  • QuidelOrtho Corp.
  • Siemens Healthineers AG
  • Sysmex Corp.
  • Thermo Fisher Scientific Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business laboratory environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Key Market Customer Landscape

The Market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth and forecasting strategies.

Global Market Customer Landscape

Market Analyst Overview

The in vitro diagnostics market is a crucial component of the healthcare industry, as reflected in comprehensive market analysis and reports. This market encompasses various segments, including products & services, techniques, applications, end-users, and regions, catering to diverse healthcare needs worldwide.

Technological advancements have led to the emergence of innovative techniques such as liquid biopsy and rapid diagnostic testing, revolutionizing disease diagnosis and preventive care testing. These advancements are particularly vital in the field of oncology, where early detection can significantly impact patient outcomes.

In emerging markets and emerging economies, there is a growing demand for personalized medicines, driving the adoption of advanced point-of-care devices and next-generation sequencing technologies. However, challenges such as budget constraints and economic downturns can hinder market growth.

Regulatory guidelines and the reimbursement scenario play a crucial role in determining the adoption of semi-automated and fully automated instruments across reference laboratories and clinical laboratories. These facilities rely on specialized equipment to conduct medical tests on various bodily fluids and tissues.

Key players in the market offer a range of solutions, including reagents & kits, software & services, and tissue diagnostics, catering to different healthcare providers such as supermarkets, hypermarkets, pharmacies, drug stores, online providers, and standalone laboratories.

Breakthrough innovations like CE-IVD Cancer Testing Kits and Companion diagnostic (CDx) are driving advancements in early cancer detection and personalized treatment pathways. With real-time reverse transcription PCR-based diagnostic kits and a Next-generation sequencing (NGS) portfolio, the in vitro diagnostics market continues to evolve to meet the dynamic needs of modern healthcare.

Segment Overview

The market report forecasts market growth by revenue at global, regional & country levels and analyzes the latest trends and growth opportunities from 2018 to 2028. 

  • Product Type Outlook
    • Reagents and kits
    • Instruments
    • Others
  • Technology Outlook
    • Immunoassay
    • Molecular diagnostics
    • Clinical chemistry
    • Hematology
    • Others
  • Geography Outlook
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • Rest of the World (ROW)
      • Australia
      • Argentina
      • Brazil

In vitro Diagnostic Industry Scope

Report Coverage

Details

Page number

179

Base year

2023

Historic period

2018-2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 4.21%

Market Growth 2024-2028

USD 22.17 billion

Market structure

Fragmented

YoY growth 2023-2024(%)

3.73

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 39%

Key countries

US, Canada, Germany, China, and Japan

Competitive landscape

 Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Key companies profiled

Abbott Laboratories, Agilent Technologies Inc., ARKRAY Inc., Becton Dickinson and Co., BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., bioMerieux SA, Charles River Laboratories International Inc., Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., Grifols SA, Illumina Inc., Merck KGaA, QIAGEN NV, Quest Diagnostics Inc., QuidelOrtho Corp., Siemens Healthineers AG, Sysmex Corp., and Thermo Fisher Scientific Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. 

Customization purview

If our market growth analysis  report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Market Research and Growth Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the  market between 2024 and 2028
  • Precise estimation of the market size and its contribution of the market in focus to the parent market
  • Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
  • Companies landscape comparing criticality of inputs and factors of differentiation
  • Exclusive Matrix on companies position and classification
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
  • Thorough analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Product Type
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Technology
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2023
    • 3.4 Market outlook: Forecast for 2023-2028
      • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

    4 Historic Market Size

    • 4.1 Global in-vitro diagnostics market 2018 - 2022
      • Exhibit 18: Historic Market Size – Data Table on global in-vitro diagnostics market 2018 - 2022 ($ billion)
    • 4.2 Product Type Segment Analysis 2018 - 2022
      • Exhibit 19: Historic Market Size – Product Type Segment 2018 - 2022 ($ billion)
    • 4.3 Technology Segment Analysis 2018 - 2022
      • Exhibit 20: Historic Market Size – Technology Segment 2018 - 2022 ($ billion)
    • 4.4 Geography Segment Analysis 2018 - 2022
      • Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ billion)
    • 4.5 Country Segment Analysis 2018 - 2022
      • Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ billion)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

    6 Market Segmentation by Product Type

    • 6.1 Market segments
      • Exhibit 30: Chart on Product Type - Market share 2023-2028 (%)
      • Exhibit 31: Data Table on Product Type - Market share 2023-2028 (%)
    • 6.2 Comparison by Product Type
      • Exhibit 32: Chart on Comparison by Product Type
      • Exhibit 33: Data Table on Comparison by Product Type
    • 6.3 Reagents and kits - Market size and forecast 2023-2028
      • Exhibit 34: Chart on Reagents and kits - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 35: Data Table on Reagents and kits - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 36: Chart on Reagents and kits - Year-over-year growth 2023-2028 (%)
      • Exhibit 37: Data Table on Reagents and kits - Year-over-year growth 2023-2028 (%)
    • 6.4 Instruments - Market size and forecast 2023-2028
      • Exhibit 38: Chart on Instruments - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 39: Data Table on Instruments - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 40: Chart on Instruments - Year-over-year growth 2023-2028 (%)
      • Exhibit 41: Data Table on Instruments - Year-over-year growth 2023-2028 (%)
    • 6.5 Others - Market size and forecast 2023-2028
      • Exhibit 42: Chart on Others - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 43: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 44: Chart on Others - Year-over-year growth 2023-2028 (%)
      • Exhibit 45: Data Table on Others - Year-over-year growth 2023-2028 (%)
    • 6.6 Market opportunity by Product Type
      • Exhibit 46: Market opportunity by Product Type ($ billion)
      • Exhibit 47: Data Table on Market opportunity by Product Type ($ billion)

    7 Market Segmentation by Technology

    • 7.1 Market segments
      • Exhibit 48: Chart on Technology - Market share 2023-2028 (%)
      • Exhibit 49: Data Table on Technology - Market share 2023-2028 (%)
    • 7.2 Comparison by Technology
      • Exhibit 50: Chart on Comparison by Technology
      • Exhibit 51: Data Table on Comparison by Technology
    • 7.3 Immunoassay - Market size and forecast 2023-2028
      • Exhibit 52: Chart on Immunoassay - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 53: Data Table on Immunoassay - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 54: Chart on Immunoassay - Year-over-year growth 2023-2028 (%)
      • Exhibit 55: Data Table on Immunoassay - Year-over-year growth 2023-2028 (%)
    • 7.4 Molecular diagnostics - Market size and forecast 2023-2028
      • Exhibit 56: Chart on Molecular diagnostics - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 57: Data Table on Molecular diagnostics - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 58: Chart on Molecular diagnostics - Year-over-year growth 2023-2028 (%)
      • Exhibit 59: Data Table on Molecular diagnostics - Year-over-year growth 2023-2028 (%)
    • 7.5 Clinical chemistry - Market size and forecast 2023-2028
      • Exhibit 60: Chart on Clinical chemistry - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 61: Data Table on Clinical chemistry - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 62: Chart on Clinical chemistry - Year-over-year growth 2023-2028 (%)
      • Exhibit 63: Data Table on Clinical chemistry - Year-over-year growth 2023-2028 (%)
    • 7.6 Hematology - Market size and forecast 2023-2028
      • Exhibit 64: Chart on Hematology - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 65: Data Table on Hematology - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 66: Chart on Hematology - Year-over-year growth 2023-2028 (%)
      • Exhibit 67: Data Table on Hematology - Year-over-year growth 2023-2028 (%)
    • 7.7 Others - Market size and forecast 2023-2028
      • Exhibit 68: Chart on Others - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 69: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 70: Chart on Others - Year-over-year growth 2023-2028 (%)
      • Exhibit 71: Data Table on Others - Year-over-year growth 2023-2028 (%)
    • 7.8 Market opportunity by Technology
      • Exhibit 72: Market opportunity by Technology ($ billion)
      • Exhibit 73: Data Table on Market opportunity by Technology ($ billion)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 75: Chart on Market share by geography 2023-2028 (%)
      • Exhibit 76: Data Table on Market share by geography 2023-2028 (%)
    • 9.2 Geographic comparison
      • Exhibit 77: Chart on Geographic comparison
      • Exhibit 78: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2023-2028
      • Exhibit 79: Chart on North America - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 80: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 81: Chart on North America - Year-over-year growth 2023-2028 (%)
      • Exhibit 82: Data Table on North America - Year-over-year growth 2023-2028 (%)
    • 9.4 Europe - Market size and forecast 2023-2028
      • Exhibit 83: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 84: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 85: Chart on Europe - Year-over-year growth 2023-2028 (%)
      • Exhibit 86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
    • 9.5 Asia - Market size and forecast 2023-2028
      • Exhibit 87: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 88: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 89: Chart on Asia - Year-over-year growth 2023-2028 (%)
      • Exhibit 90: Data Table on Asia - Year-over-year growth 2023-2028 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
      • Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
      • Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • 9.7 US - Market size and forecast 2023-2028
      • Exhibit 95: Chart on US - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 96: Data Table on US - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 97: Chart on US - Year-over-year growth 2023-2028 (%)
      • Exhibit 98: Data Table on US - Year-over-year growth 2023-2028 (%)
    • 9.8 China - Market size and forecast 2023-2028
      • Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
      • Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
    • 9.9 Germany - Market size and forecast 2023-2028
      • Exhibit 103: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 104: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 105: Chart on Germany - Year-over-year growth 2023-2028 (%)
      • Exhibit 106: Data Table on Germany - Year-over-year growth 2023-2028 (%)
    • 9.10 Japan - Market size and forecast 2023-2028
      • Exhibit 107: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 108: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 109: Chart on Japan - Year-over-year growth 2023-2028 (%)
      • Exhibit 110: Data Table on Japan - Year-over-year growth 2023-2028 (%)
    • 9.11 Canada - Market size and forecast 2023-2028
      • Exhibit 111: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 112: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 113: Chart on Canada - Year-over-year growth 2023-2028 (%)
      • Exhibit 114: Data Table on Canada - Year-over-year growth 2023-2028 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 115: Market opportunity by geography ($ billion)
      • Exhibit 116: Data Tables on Market opportunity by geography ($ billion)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 117: Impact of drivers and challenges in 2023 and 2028
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 119: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 120: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 121: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 122: Matrix on vendor position and classification
            • 12.3 Abbott Laboratories
              • Exhibit 123: Abbott Laboratories - Overview
              • Exhibit 124: Abbott Laboratories - Business segments
              • Exhibit 125: Abbott Laboratories - Key news
              • Exhibit 126: Abbott Laboratories - Key offerings
              • Exhibit 127: Abbott Laboratories - Segment focus
            • 12.4 Agilent Technologies Inc.
              • Exhibit 128: Agilent Technologies Inc. - Overview
              • Exhibit 129: Agilent Technologies Inc. - Business segments
              • Exhibit 130: Agilent Technologies Inc. - Key offerings
              • Exhibit 131: Agilent Technologies Inc. - Segment focus
            • 12.5 ARKRAY Inc.
              • Exhibit 132: ARKRAY Inc. - Overview
              • Exhibit 133: ARKRAY Inc. - Product / Service
              • Exhibit 134: ARKRAY Inc. - Key offerings
            • 12.6 Becton Dickinson and Co.
              • Exhibit 135: Becton Dickinson and Co. - Overview
              • Exhibit 136: Becton Dickinson and Co. - Business segments
              • Exhibit 137: Becton Dickinson and Co. - Key news
              • Exhibit 138: Becton Dickinson and Co. - Key offerings
              • Exhibit 139: Becton Dickinson and Co. - Segment focus
            • 12.7 BGI Genomics Co. Ltd.
              • Exhibit 140: BGI Genomics Co. Ltd. - Overview
              • Exhibit 141: BGI Genomics Co. Ltd. - Product / Service
              • Exhibit 142: BGI Genomics Co. Ltd. - Key offerings
            • 12.8 Bio Rad Laboratories Inc.
              • Exhibit 143: Bio Rad Laboratories Inc. - Overview
              • Exhibit 144: Bio Rad Laboratories Inc. - Business segments
              • Exhibit 145: Bio Rad Laboratories Inc. - Key news
              • Exhibit 146: Bio Rad Laboratories Inc. - Key offerings
              • Exhibit 147: Bio Rad Laboratories Inc. - Segment focus
            • 12.9 bioMerieux SA
              • Exhibit 148: bioMerieux SA - Overview
              • Exhibit 149: bioMerieux SA - Product / Service
              • Exhibit 150: bioMerieux SA - Key offerings
            • 12.10 Danaher Corp.
              • Exhibit 151: Danaher Corp. - Overview
              • Exhibit 152: Danaher Corp. - Business segments
              • Exhibit 153: Danaher Corp. - Key news
              • Exhibit 154: Danaher Corp. - Key offerings
              • Exhibit 155: Danaher Corp. - Segment focus
            • 12.11 DiaSorin SpA
              • Exhibit 156: DiaSorin SpA - Overview
              • Exhibit 157: DiaSorin SpA - Business segments
              • Exhibit 158: DiaSorin SpA - Key news
              • Exhibit 159: DiaSorin SpA - Key offerings
              • Exhibit 160: DiaSorin SpA - Segment focus
            • 12.12 F. Hoffmann La Roche Ltd.
              • Exhibit 161: F. Hoffmann La Roche Ltd. - Overview
              • Exhibit 162: F. Hoffmann La Roche Ltd. - Business segments
              • Exhibit 163: F. Hoffmann La Roche Ltd. - Key news
              • Exhibit 164: F. Hoffmann La Roche Ltd. - Key offerings
              • Exhibit 165: F. Hoffmann La Roche Ltd. - Segment focus
            • 12.13 Grifols SA
              • Exhibit 166: Grifols SA - Overview
              • Exhibit 167: Grifols SA - Business segments
              • Exhibit 168: Grifols SA - Key offerings
              • Exhibit 169: Grifols SA - Segment focus
            • 12.14 Illumina Inc.
              • Exhibit 170: Illumina Inc. - Overview
              • Exhibit 171: Illumina Inc. - Business segments
              • Exhibit 172: Illumina Inc. - Key news
              • Exhibit 173: Illumina Inc. - Key offerings
              • Exhibit 174: Illumina Inc. - Segment focus
            • 12.15 QIAGEN NV
              • Exhibit 175: QIAGEN NV - Overview
              • Exhibit 176: QIAGEN NV - Product / Service
              • Exhibit 177: QIAGEN NV - Key news
              • Exhibit 178: QIAGEN NV - Key offerings
            • 12.16 Quest Diagnostics Inc.
              • Exhibit 179: Quest Diagnostics Inc. - Overview
              • Exhibit 180: Quest Diagnostics Inc. - Business segments
              • Exhibit 181: Quest Diagnostics Inc. - Key offerings
              • Exhibit 182: Quest Diagnostics Inc. - Segment focus
            • 12.17 QuidelOrtho Corp.
              • Exhibit 183: QuidelOrtho Corp. - Overview
              • Exhibit 184: QuidelOrtho Corp. - Product / Service
              • Exhibit 185: QuidelOrtho Corp. - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 186: Inclusions checklist
                • Exhibit 187: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 188: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 189: Research methodology
                • Exhibit 190: Validation techniques employed for market sizing
                • Exhibit 191: Information sources
              • 13.5 List of abbreviations
                • Exhibit 192: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              in-vitro diagnostics market market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis